Re:The Mark Cuban Cost Plus Drug Company
by DevKoala on Thursday January 28, 2021 @12:26PM
(#25945224)
That’s selective quoting. The study states in the abstract the top selling drugs saw price increases. Here is the full abstract.
> The results show that the average annual price of top-selling cancer drugs in 2006, adjusted for inflation and secular changes in drug prices, have increased by US$154 and US$235 for branded and competitive brand drugs, respectively, following the 2010 ACA; however, generic oncology drug prices showed no significant changes.
> The results show that the average annual price of top-selling cancer drugs in 2006, adjusted for inflation and secular changes in drug prices, have increased by US$154 and US$235 for branded and competitive brand drugs, respectively, following the 2010 ACA; however, generic oncology drug prices showed no significant changes.